Further research and clinical studies are required to assess the importance of assessing PD-1 and PD-L1 in DLBCL, NOS patients as well as methods to determine their expression, particularly with regard to planning immunotherapy treatments. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.